Crossmark

Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.06.005

Published Print: 2022-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morell-Hita, Jose Luis

Rigual-Bobillo, Juan A.

Macía-Villa, Cristina C. http://orcid.org/0000-0002-6822-6730
License Information

Text and Data Mining valid from 2022-12-01
More Information

This article is maintained by: Elsevier

Article Title: Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.06.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.06.002

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.